№ lp_1_2_11591
File format: docx
Character count: 14116
File size: 69 KB
This document provides a guide specification for the use of Sika products, specifically focusing on the application of a waterproof coating, detailing technical requirements, material properties, and execution guidelines for the specified product in construction projects.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Document Type:
Guide Specification
Organization / Institution:
Sika Corporation
Target Audience:
Specifiers, Architects, Engineers
Year:
2026
Region / City:
Canton, MA, USA
Document Type:
Installation Specification
Organization:
Sika Corporation
Author:
Sika Corporation Technical Services
Target Audience:
Roofing Applicators, Licensed Electricians
Scope:
Installation of Sarnafil adhered roofing system with SSM-2 PV module racking system, including membrane, flashings, insulation, and related components
Warranty:
Sika Corporation Warranty, Roofing Applicator Warranty
Standards Compliance:
ASCE 7, FM Global 4470, UL 2703, UL 1703
Safety Guidelines:
OSHA regulations, SDS handling instructions
Storage Conditions:
Temperature 4°C–27°C for adhesives, protection from moisture and fire hazards
Note:
Year
Document Type:
Guide Specification
Organization / Institution:
Sika Corporation
Target Audience:
Specifiers, Architects, Engineers
Year:
2023
Region / City:
Lyndhurst, NJ
Topic:
Construction materials specification
Document Type:
Guide Specification
Organization / Institution:
Sika Corporation
Author:
Sika Corporation
Target Audience:
Architects, engineers, construction professionals
Period of validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
KHG Housing Strategy and Enabling Subgroup Meeting Notes, 13th January 2026, 2:00 – 3:30pm, on Teams
Year:
2026
Region / City:
Kent & Medway
Topic:
Housing Strategy and Affordable Housing
Document Type:
Meeting Notes
Organization:
Kent Housing Group (KHG)
Author:
N/A
Target Audience:
KHG members, local authorities, housing professionals
Period of Effectiveness:
N/A
Approval Date:
13th January 2026
Date of Changes:
N/A
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Year:
2019
Region / City:
San Clemente, CA
Subject:
Criminal Law
Document Type:
Course Outline
Institution:
Grossmont College
Author:
Richard Michelson, James Zuffoletto, M. R. Lippman
Target Audience:
Students of Criminal Justice
Period of Application:
Fall Semester 2019
Approval Date:
December 13, 2019
Location:
Academic Senate Conference Room (AS 125)
Year:
2019
Region / City:
Long Beach, California
Subject:
Executive Committee Meeting Minutes
Document Type:
Meeting Minutes
Organization / Institution:
California State University, Long Beach (CSULB)
Author:
J. Pandya, N. Hultgren, M. Aliasgari, N. Meyer-Adams, C. Cummings, P. Hung, D. Stewart, N. Schürer, K. Janousek, E. Klink, P. Soni, J. Phillips, D. Hamm, K. Bonetati, J. Hamilton, S. Apel, B. Jersky, J. Cormack, A. Kinsey
Target Audience:
Faculty, Academic Senate, Executive Committee members
Period of Validity:
Not specified
Approval Date:
August 27, 2019
Amendment Date:
Not specified
Year:
2026
Region / City:
Northport, New York
Topic:
Roof Replacement, Architectural Design
Document Type:
Design Submission Instructions
Institution:
Department of Veterans Affairs
Author:
Department of Veterans Affairs
Target Audience:
Architects/Engineers involved in VA projects
Effective Period:
Ongoing
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / City:
Australia
Subject:
Pharmacology, Pharmaceutical Benefits Scheme (PBS)
Document Type:
Submission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval Date:
3 June 2022
Date of Changes:
Not specified
Contextual Description:
A regulatory submission detailing the request for listing of dupilumab in new forms for treating severe atopic dermatitis and uncontrolled severe asthma in pediatric patients under the PBS.
Year:
2013
Region / City:
Hillston
Topic:
Annual General Meeting, Water Policy, Agriculture, Irrigation
Document Type:
Meeting Minutes
Organization:
Lachlan Valley Water Inc
Author:
Dennis Moxey (Chairman)
Target Audience:
Members of Lachlan Valley Water Inc, Stakeholders in Water and Irrigation Policy
Period of Action:
12 September 2013
Approval Date:
12 September 2013
Date of Changes:
Not specified
Note:
Year
Document Type:
Policy Template
Governing Body:
State Water Board
Intended Audience:
Public Water System Operators
Service Connections Covered:
Single-family, Multifamily, Commercial, Industrial, Agricultural, Landscape
Legal Authority:
Operating rules / Ordinance / Board resolution / Bylaw
Certification Requirements:
ANSI/DDW recognized cross-connection control specialist
Inspection Frequency:
Initial and ongoing hazard assessments
Backflow Prevention Requirements:
Inventory, testing, maintenance, corrective actions
Incident Response:
Reporting and notification procedures
Public Outreach:
Education methods for customers, staff, and community
Year:
2024
Region / City:
Raleigh
Theme:
Office Space Leasing
Document Type:
Proposal
Agency / Organization:
North Carolina Department of Revenue
Author:
Sam Tucker
Target Audience:
Proposers
Effective Date:
October 17, 2024
Deadline for Proposal Submission:
October 23, 2024 at 4:00 PM ET
Electronic Submission Portal:
NC eProcurement Electronic Vendor Portal
Proposal Number:
92-966-FINAL
Year:
2022
Region / City:
Australia
Theme:
Oncology, Medical Treatment
Document Type:
Pharmaceutical Submission
Organization / Institution:
Bristol-Myers Squibb Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, Oncologists
Period of validity:
Ongoing
Approval Date:
4 July 2018
Date of Changes:
Not specified
Note:
Contextual Description
Year:
2021
Region / City:
Australia
Topic:
Atopic dermatitis treatment, medication submission
Document Type:
Submission report
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Sanofi-Aventis
Target Audience:
Medical professionals, regulatory authorities
Action Period:
Ongoing treatment evaluation
Approval Date:
17 August 2021
Modification Date:
Not specified
Background:
Dupilumab registration history
Clinical Claim:
Dupilumab has superior efficacy compared to standard care for children with severe atopic dermatitis
Episodicity:
Chronic
Severity:
Severe
Condition:
Atopic dermatitis
PBS Indication:
Chronic severe atopic dermatitis
Prescriber Type:
Medical practitioners, dermatologists, clinical immunologists
Treatment Phase:
Initial, continuing
Population Criteria:
Children aged 6 to 11 years, specific weight ranges
Comparator:
Placebo
Outcomes:
EASI-75, IGA 0 or 1 at Week 16, improvement in itch score
Dosing:
Tiered by body weight
Cost:
$1,754.28–$3,380.91
Price:
Published price for maximum quantity
Form:
Pre-filled syringe
Medical Information:
Dupilumab 300 mg/2 mL, 200 mg/1.14 mL
Note:
Comparator
Standard of care (Placebo)
Source:
PBAC submission
Year:
2019
Region / City:
Vancouver, WA
Theme:
Diversity, Equity, Legislative Action, Community Outreach
Document Type:
Meeting Minutes
Organization:
CAPAA
Author:
Lisa Dickinson, Nam Nguyen, Carrie Huie-Pascua, Lori Wada, Tam Dinh, Mohan Gurung, Ekkarath Sisavatdy, Sam Cho, Sina Sam, Helen Christensen, Lydia Faitalia
Target Audience:
CAPAA Members, Community Leaders, Public Health Advocates, Immigrant Communities
Period of Activity:
September 21, 2019
Date of Approval:
September 21, 2019
Date of Changes:
N/A
Year:
2026
Region / City:
New South Wales, Australia
Topic:
Computing Technology
Document Type:
Curriculum
Institution:
NSW Department of Education
Author:
NSW Department of Education
Target Audience:
Teachers in New South Wales public schools
Duration:
200 hours
Approval Date:
2026
Modification Date:
N/A
Year:
2022
Region / City:
New South Wales, Australia
Subject:
Computing Technology
Document Type:
Assessment schedule
Author:
NSW Education Standards Authority (NESA)
Target Audience:
Teachers in NSW public schools
Period:
Stage 5 (Years 9-10)
Approval Date:
2022
Date of Last Update:
2022
Year:
2020
Region / City:
Long Beach, CA
Topic:
Academic Senate Meeting Minutes
Document Type:
Meeting Minutes
Organization:
California State University, Long Beach
Author:
Academic Senate
Target Audience:
University faculty, staff, and students
Period of Validity:
September 10, 2020
Approval Date:
September 10, 2020
Date of Changes:
None
Contextual description:
Meeting minutes detailing the discussions and decisions made during the Academic Senate meeting at California State University, Long Beach, on September 10, 2020.